Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 20
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT02757326 | ABC294640 (Opaganib) in Refractory / Relapsed Multiple Myeloma | ||
| NCT01951326 | Efficacy and Safety of Anti-MAP Therapy in Adult Crohn's Disease | ||
| NCT03414489 | Expanded Access for the Treatment of Advanced Cholangiocarcinoma With ABC294640 (Yeliva ®) | ||
| NCT04027894 | Study to Evaluate Safety and Efficacy of Rifamycin SV MMX in Treating Traveler's Diarrhea in Children Age 12 to 17 Years | ||
| NCT02246439 | BEKINDA (Ondansetron 24 mg Bimodal Release Tablets) for Vomiting Due to Presumed Acute Gastroenteritis or Gastritis | ||
| NCT05954286 | PROTECT-APT 1: Early Treatment and Post-Exposure Prophylaxis of COVID-19 | ||
| NCT03009396 | Open Label Efficacy and Safety of Anti-MAP (Mycobacterium Avium Ssp. Paratuberculosis) Therapy in Adult Crohn's Disease | ||
| NCT04026984 | Evaluate Safety and Efficacy of Rifamycin SV MMX in the Treatment of Traveler's Diarrhea in Children Age 6 to 11 Years | ||
| NCT02229981 | Early Phase Evaluation of ABC294640 in Patients With Refractory/Relapsed Diffuse Large B-cell Lymphoma or Kaposi Sarcoma | ||
| NCT04502069 | Treatment of COVID-19 With Opaganib in Patients With Pneumonia Requiring Oxygen | ||
| NCT04467840 | Opaganib, a Sphingosine Kinase-2 (SK2) Inhibitor in COVID-19 Pneumonia | ||
| NCT04616924 | RHB-204 for the Treatment of Pulmonary Mycobacterium Avium Complex Disease | ||
| NCT01980095 | ERADICATE Hp - Treating Helicobacter Pylori With RHB-105 | ||
| NCT04414618 | A Study of Opaganib in Coronavirus Disease 2019 Pneumonia | ||
| NCT01488513 | ABC294640 in Treating Patients With Advanced Solid Tumors | ||
| NCT03377179 | A Study of ABC294640 (Yeliva ®) Alone and in Combination With Hydroxychloroquine Sulfate in Treatment of Patients With Advanced Cholangiocarcinoma | ||
| NCT01717664 | Proof of Concept Study of RHB-104 as Add-On Therapy to Interferon Beta-1a in Relapsing Remitting Multiple Sclerosis (RRMS) | ||
| NCT03198507 | ERADICATE Hp2 - Treating Helicobacter Pylori With RHB-105 Compared to Active Comparator | ||
| NCT04723537 | Upamostat, a Serine Protease Inhibitor, or Placebo for Treatment of COVID-19 Disease | ||
| NCT02757105 | Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial of BEKINDA (Ondansetron 12 mg Bimodal Release Tablets) for Diarrhea Predominant Irritable Bowel Syndrome (IBS-D) |
